Investigation of osteoporosis

Clinical Endocrinology

Volumn 44, Issue 4, 1996, Pages 371-374

  Smith, R ^a  

^a NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; ESTROGEN; ETIDRONIC ACID; GESTAGEN; VITAMIN D;

BONE MINERAL; HUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0029985922     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.702520.x     Document Type: Short Survey

References (9)

1. Compston, J.E. (1995) Bone density: BMC, BMD or corrected BMD. Bone, 16, 5-7.
2. Dempster, D.W. & Lindsay, R. (1993) Pathogenesis of osteoporosis. Lancet, 341, 797-801.
3. Eastell, R. & Peel, N.F.A. (1994) Interpretation of bone density results. Osteoporosis Review, 2, 1-4.
4. Hassager, C. & Christiansen, C. (1995) Measurement of bone mineral density. Calcified Tissue International, 57, 1-5.
5. Kanis, J.A., Melton, L.J., Christiansen, C., Johnston, C.C. & Khaltaev, N. (1994) The diagnosis of osteoporosis. Journal of Bone and Mineral Research, 9, 1137-1141.
6. Lancet (1993) Editorial. Pyridinium cross-links as markers of bone resorption, Lancet, 340, 278-279.
7. Peel, N. & Eastell, R. (1993) Measurement of bone mass and turnover. Ballières Clinical Rheumatology, 7, 479-498.
8. Reid, D. (1993) Osteoporosis. Ballières Clinical Rheumatology, 7, 421-640.
9. Smith, R. (1994) Prevention and treatment of osteoporosis: common sense and science coincide. Journal of Bone and Joint Surgery B, 76, 345-347.